Advances in cancer drug therapy have led to improvements in the outcomes of cancer
patients, as well as increasing numbers of patients undergoing anticancer chemotherapy …

Anticancer drug nephrotoxicity is an important and increasing adverse drug event that limits
the efficacy of cancer treatment. The kidney is an important elimination pathway for many …

The relation that connects cancer and renal damage is bidirectional and this renal damage
worsens quality of life and increases morbidity in high-complexity patients such as patients …

Acute and chronic kidney disease encompasses a complex set of diseases that can both
lead to, and result from, cancer. In particular, kidney disease can arise from the use of …

Conventional chemotherapies remain the mainstay of treatment for many malignancies.
Kidney complications of these therapies are not infrequent and may have serious …

Renal function is an important consideration in the management of patients with advanced
cancer. There is a reciprocal relationship between cancer and the kidney: chronic kidney …

New anticancer medications are rapidly entering the clinical arena offering patients with
previously resistant cancers the promise of more effective therapies capable of extending …

In the last several decades, advancements in chemotherapy have improved the overall
survival of cancer patients. These agents, however, are associated with adverse effects …

The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …

Nephrotoxic effects of certain chemotherapeutic agents such as cisplatin and ifosfamide has
been well documented and these effects are carefully managed by oncologists during their …